Here, we compared the epigenetic profile of a GBM tumor and of a “residual tumor” obtained after si-hVDAC1 treatment, and which displayed a reversal of the oncogenic metabolism and other cancer-related properties, in order to identify alterations in the epigenetic landscape caused by cell depletion of VDAC1. The gene discussed is VDAC1; the disease is glioblastoma.